Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner
- 63 Downloads
Single-chain variable fragment (scFv) has great prospect in medical therapies and diagnostic applications due to its binding affinity and low immunogenicity. However, the application of scFv is limited by its heterologous expression facing challenges of insoluble aggregation. sfGFP has been developed as fusion tag to facilitate the solubility of fusion partner in Escherichia coli. We designed fusion protein of anti-influenza PB2 scFv at C-terminus of sfGFP and successfully obtained soluble expression of sfGFP-scFv-His in Escherichia coli. The expression level of sfGFP-scFv-His reached at 20 mg/L of bacterial culture when the culture was induced with 0.1 mM IPTG at 18 °C for 16 h. And 6 mg scFv-His was obtained from the cleavage of 10 mg pure sfGFP-scFv-His with TEV protease. In addition, we found that sfGFP-scFv-His was more stable than scFv-His in chicken serum, suggesting that sfGFP not only facilitated the solubility of scFv in Escherichia coli, but also promoted the stability of scFv. The immunologic activity of sfGFP-scFv-His was confirmed by Western blot and ELISA; the results showed that anti-PB2 sfGFP-scFv-His exhibited specific binding to PB2. Hemagglutination and comparative real-time RT-PCR analysis indicated that sfGFP-scFv-His and scFv-His inhibited the replication of H1N1 influenza virus in the infected A549 cells. These results further develop the application of scFv as an agent, such as anti-influenza. Furthermore, soluble expression of scFv using sfGFP as fusion partner provide a cost-effective preparation model for manufacturing scFv against pandemic disease.
KeywordsscFv sfGFP Escherichia coli High solubility Influenza virus
Min Liu, Bin Wang, and Fei Wang performed the experiments and analyzed the data. Min Liu wrote the manuscript. Zhi Yang, Dan Gao, and Chenyao Zhang carried out the experiments. Xiaolan Yu and Lixin Ma designed the study and revised the manuscript.
The work was supported by National Natural Science Foundation of China (Grant No. 31672561).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Barcena J, Ochoa M, delaLuna S, Melero JA, Nieto A, Ortin J, Portela A (1994) Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol 68:6900–6909Google Scholar
- Gao Y, Sun L, Dong J, Xu X, ShuY CM, Yin L, Liang Z, Jin Q (2006) Rapid identification of small interfering RNA that can effectively inhibit the replication of multiple influenza B virus strains. Antivir Ther 11:431–438Google Scholar
- Hao SM, Li Q, Wang CY, Wang HL, Yang ST, Xia XZ (2009) Cloning and expression of single chain Fv antibodies against H5N1 avian influenza virus hemagglutinin. Bing Du Xue Bao 25:63–67Google Scholar
- Maneewatch S, Thanongsaksrikul J, Songserm T, Thueng-In K, Kulkeaw K, Thathaisong U, Srimanote P, Tongtawe P, Tapchaisri P, Chaicumpa W (2009) Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1. Antivir Ther 14:221–230Google Scholar
- Popplewell AG, Sehdev M, Spitali M, Weir AN (2005) Expression of antibody fragments by periplasmic secretion in Escherichia coli. Methods Mol Biol 308:17–30Google Scholar
- Schaefer JV, Plückthun A (2010) Improving expression of scFv fragments by co-expression of periplasmic chaperones. In: Kontermann R, Dübel S (eds) Antibody engineering. Springer, Berlin, HeidelbergGoogle Scholar
- Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67:1761–1764Google Scholar
- Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I (2004) IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85:1801–1813Google Scholar
- Umetsu M, Tsumoto K, Hara M, Ashish K, Goda S, Adschiri T, Kumagai I (2003) How additives influence the refolding of immunoglobulinfolded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J Biol Chem 278:8979–8987CrossRefGoogle Scholar
- Yodsheewan R, Maneewatch S, Srimanote P, Thueng-in K, Songserm T, Dong-din-on F, Bangphoomi K, Sookrung N, Choowongkomon K, Chaicumpa W (2013) Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes. Antiviral Res 100:226–237Google Scholar
- Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402–3408Google Scholar